These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 29155989)
1. 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model. Zhang K; Dong C; Fujita Y; Fujita A; Hashimoto K Int J Neuropsychopharmacol; 2018 Feb; 21(2):157-163. PubMed ID: 29155989 [TBL] [Abstract][Full Text] [Related]
2. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine. Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360 [TBL] [Abstract][Full Text] [Related]
3. Lack of Antidepressant Effects of Low-Voltage-Sensitive T-Type Calcium Channel Blocker Ethosuximide in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine. Tian Z; Dong C; Zhang K; Chang L; Hashimoto K Int J Neuropsychopharmacol; 2018 Nov; 21(11):1031-1036. PubMed ID: 30085247 [TBL] [Abstract][Full Text] [Related]
4. Lack of dopamine D Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Shirayama Y; Hashimoto K Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):271-275. PubMed ID: 30927075 [TBL] [Abstract][Full Text] [Related]
5. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine. Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808 [TBL] [Abstract][Full Text] [Related]
6. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193 [TBL] [Abstract][Full Text] [Related]
7. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model. Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218 [TBL] [Abstract][Full Text] [Related]
8. Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABA Xiong Z; Zhang K; Ishima T; Ren Q; Chang L; Chen J; Hashimoto K Pharmacol Biochem Behav; 2018 Dec; 175():139-145. PubMed ID: 30359627 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model. Yang C; Ren Q; Qu Y; Zhang JC; Ma M; Dong C; Hashimoto K Biol Psychiatry; 2018 Jan; 83(1):18-28. PubMed ID: 28651788 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614 [TBL] [Abstract][Full Text] [Related]
11. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model. Zhang K; Fujita Y; Hashimoto K Sci Rep; 2018 Mar; 8(1):4007. PubMed ID: 29507385 [TBL] [Abstract][Full Text] [Related]
12. Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model. Yang C; Qu Y; Fujita Y; Ren Q; Ma M; Dong C; Hashimoto K Transl Psychiatry; 2017 Dec; 7(12):1294. PubMed ID: 29249803 [TBL] [Abstract][Full Text] [Related]
13. Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model. Zhang K; Ma M; Dong C; Hashimoto K Int J Neuropsychopharmacol; 2018 Nov; 21(11):1025-1030. PubMed ID: 30032169 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram. Dong C; Tian Z; Fujita Y; Fujita A; Hino N; Iijima M; Hashimoto K Pharmacol Biochem Behav; 2022 Jan; 212():173316. PubMed ID: 34968554 [TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling. Wei Y; Chang L; Hashimoto K Eur Neuropsychopharmacol; 2021 Sep; 50():55-63. PubMed ID: 33971385 [TBL] [Abstract][Full Text] [Related]
16. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Ren Q; Dong C; Fujita Y; Hashimoto K Pharmacol Biochem Behav; 2019 Jun; 181():53-59. PubMed ID: 31034852 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model. Yang B; Ren Q; Ma M; Chen QX; Hashimoto K Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608811 [TBL] [Abstract][Full Text] [Related]
18. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway. Jiang B; Wang F; Yang S; Fang P; Deng ZF; Xiao JL; Hu ZL; Chen JG Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522427 [TBL] [Abstract][Full Text] [Related]
19. Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine. Zhang K; Sakamoto A; Chang L; Qu Y; Wang S; Pu Y; Tan Y; Wang X; Fujita Y; Ishima T; Hatano M; Hashimoto K Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):447-456. PubMed ID: 31875248 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model. Xiong Z; Fujita Y; Zhang K; Pu Y; Chang L; Ma M; Chen J; Hashimoto K Behav Brain Res; 2019 Aug; 368():111904. PubMed ID: 30980851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]